A detailed history of Rmr Wealth Builders transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Rmr Wealth Builders holds 4,194 shares of EW stock, worth $284,185. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,194
Previous 4,167 0.65%
Holding current value
$284,185
Previous $384,000 28.13%
% of portfolio
0.03%
Previous 0.04%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$59.7 - $93.78 $1,611 - $2,532
27 Added 0.65%
4,194 $276,000
Q2 2024

Jul 23, 2024

SELL
$84.3 - $94.31 $3,793 - $4,243
-45 Reduced 1.07%
4,167 $384,000
Q1 2024

Apr 15, 2024

BUY
$72.54 - $95.56 $3,264 - $4,300
45 Added 1.08%
4,212 $402,000
Q1 2023

Apr 11, 2023

SELL
$74.26 - $84.51 $25,396 - $28,902
-342 Reduced 7.58%
4,167 $344,000
Q4 2022

Feb 15, 2023

BUY
$68.3 - $87.44 $307,964 - $394,266
4,509 New
4,509 $336,000
Q3 2022

Nov 08, 2022

SELL
$82.37 - $107.29 $109,963 - $143,232
-1,335 Reduced 22.84%
4,509 $373,000
Q2 2022

Aug 02, 2022

SELL
$86.5 - $128.27 $144,801 - $214,723
-1,674 Reduced 22.27%
5,844 $556,000
Q1 2022

May 13, 2022

BUY
$101.96 - $128.34 $766,535 - $964,860
7,518 New
7,518 $885,000
Q4 2021

Feb 02, 2022

SELL
$106.37 - $130.68 $799,689 - $982,452
-7,518 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$78.68 - $90.67 $26,908 - $31,009
342 Added 4.77%
7,518 $629,000
Q4 2020

Feb 26, 2021

BUY
$71.69 - $91.23 $301,313 - $383,439
4,203 Added 141.37%
7,176 $655,000
Q4 2020

Feb 09, 2021

SELL
$71.69 - $91.23 $325,831 - $414,640
-4,545 Reduced 60.45%
2,973 $655,000
Q3 2020

Nov 13, 2020

BUY
$67.19 - $87.44 $22,978 - $29,904
342 Added 4.77%
7,518 $600,000
Q2 2020

Aug 19, 2020

BUY
$57.54 - $76.95 $275,271 - $368,128
4,784 Added 200.0%
7,176 $496,000
Q4 2019

Mar 03, 2020

BUY
$71.7 - $82.09 $171,506 - $196,359
2,392 New
2,392 $558,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Rmr Wealth Builders Portfolio

Follow Rmr Wealth Builders and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rmr Wealth Builders, based on Form 13F filings with the SEC.

News

Stay updated on Rmr Wealth Builders with notifications on news.